News & Updates

Kedalion Therapeutics Names Ehud Ivri Chief Technology Officer

Kedalion Therapeutics Adds Dana G. Mead, Jr. to Board of Directors

Kedalion Therapeutics Completes Two Phase I Clinical Studies

Kedalion Therapeutics Appoints Peter Noymer President & CEO

Kedalion Therapeutics Presents Data from AcuStream™ Studies at the Ophthalmology Innovation Summit (OIS)

Kedalion Therapeutics Closes $5 Million Series A Financing Round

Kedalion Therapeutics Broadens Leadership Team with Vice President of Engineering

Kedalion Therapeutics to Present at 2018 BIO Investor Forum

Kedalion Therapeutics to Present at Biotech Showcase 2019

Kedalion Therapeutics’ AcuStream™ Technology Featured in ONdrugDelivery